Professor Jaap van Laar interviews Dr Helena Andersson, Oslo University, regarding her study on long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
